$GPCR News

Structure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now

Structure Therapeutics: My Top Small-Cap Pick For The Obesity Market (Upgrade)

HC Wainwright & Co. Maintains Buy on Structure Therapeutics, Lowers Price Target to $70

Structure Therapeutics Inc. (GPCR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Structure Therapeutics (GPCR) Reports Positive Phase 2 Weight Loss Data for Aleniglipron

Does Phase 2b Oral GLP-1 Data on Aleniglipron Change The Bull Case For Structure Therapeutics (GPCR)?

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Structure Therapeutics Publishes Phase 2b Aleniglipron Results In Nature Medicine, Reporting Up To 16.2% Weight Loss; Phase 3 Obesity Program On Track For Q3 2026

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

Structure Therapeutics Amends And Restates Sales Agreement With Leerink Partners LLC And Cantor Fitzgerald & Co. On May 7, 2026; Increases ATM Shares Offering By $150M To Aggregate $400M

Structure Therapeutics Q1 EPS $(0.35), Inline

Why Structure Therapeutics (GPCR) Is Down 7.2% After Strong Oral GLP-1 Phase 2 Data And FDA Plans

Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

Canaccord Genuity Initiates Coverage On Structure Therapeutics with Buy Rating, Announces Price Target of $101

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel

Structure Therapeutics Appoints Matthew Lang COO

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy Meets Biased-Agonism Safety Moat

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster